Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 266-270, May 2008

Vesical vs. extra-vesical patterns of recurrence after the treatment of urothelial upper tract tumors

  • Sergey Shikanov, M.D.

      Affiliations

    • Department of Urology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • ,
  • Amos Shapiro, M.D.

      Affiliations

    • Department of Urology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • ,
  • Lea Baer, M.D.

      Affiliations

    • Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • ,
  • Ezekiel H. Landau, M.D.

      Affiliations

    • Department of Urology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • ,
  • Ran Katz, M.D.

      Affiliations

    • Department of Urology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • ,
  • Ofer N. Gofrit, M.D., Ph.D

      Affiliations

    • Department of Urology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    • Corresponding Author InformationCorresponding author. Tel.: +972-2-6776874; fax: +972-2-6430929.

Received 8 February 2007; received in revised form 15 April 2007; accepted 16 April 2007. published online 14 December 2007.

Abstract 

Objective

The objective of this study was to define recurrence patterns after nephro-ureterectomy (NU) for urothelial upper tract tumor (UUTT), and to suggest guidelines for follow-up.

Methods

The effects of age, gender, UUTT grade, stage, size, location in the urinary system, and the administration of adjuvant chemotherapy on disease-free survival were assessed retrospectively.

Results

Fifty-three patients (mean age 62.7 years) underwent NU for UUTT and were followed with periodic cystoscopy, urinary cytology, and CT of the chest and abdomen. During a median follow-up period of 72 months, 26 patients (49%) developed tumor recurrence. Almost 95% of the recurrences occurred within the first 48 months following surgery. Two distinct patterns of recurrence were identified: vesical and extra-vesical recurrences. Vesical recurrence occurred in 19 patients (35.8%) and did not impair survival. The risk of vesical recurrence was independent of UUTT grade or stage. Patients who had Grades 1 or 2 UUTT developed only low-grade vesical recurrence, while patients with Grade 3 UUTT developed either high- or low-grade vesical recurrences. Extra-vesical recurrence occurred in 8 patients (15.1%); all had an initial Grade 3 UUTT, and were associated with short median survival.

Conclusions

Patients presenting with Grades 1 or 2 UUTT are at risk of developing low-grade bladder tumors. Therefore, cystoscopic surveillance is recommended. Patients presenting with Grade 3 UUTT are at risk of developing both high- and low-grade bladder tumors as well as extra-vesical recurrence. An aggressive multimodality program including cystoscopy, urinary cytology, and CT of the chest and abdomen is advisable.

Keywords: Urothelial upper tract tumors, Recurrence, Follow-up

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(07)00128-7

doi:10.1016/j.urolonc.2007.04.007

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 3 , Pages 266-270, May 2008